Veiga Zulane S T, Fernandes Flávia F, Guimarães Lívia, Piedade Juliana, Pereira Gustavo Henrique S
Gastroenterology and Hepatology Unit, Bonsucesso Federal Hospital, Ministry of Health, Rio de Janeiro 22640-100, Brazil.
School of Medicine, Estácio de Sá University, Rio de Janeiro 25550-100, Brazil.
Trop Med Infect Dis. 2023 Feb 27;8(3):145. doi: 10.3390/tropicalmed8030145.
Hepatosplenic schistosomiasis (HSS) is a peculiar form of non-cirrhotic portal hypertension (NCPH). Although HSS patients present normal hepatic function, some evolve signs of hepatocellular failure and features of decompensated cirrhosis. The natural history of HSS-NCPH is unknown.
A retrospective study was conducted that evaluated patients who fulfilled clinical-laboratorial criteria for HSS.
A total of 105 patients were included. Eleven patients already presented with decompensated disease and had lower transplant-free survival at 5 years than those without (61% vs. 95%, = 0.015). Among 94 patients without prior decompensation, the median follow-up was 62 months and 44% of them had varicose bleeding (two or more episodes in 27%). Twenty-one patients presented at least one episode of decompensation (10-year probability 38%). Upon multivariate analysis, varicose bleeding and higher bilirubin levels were associated with decompensation. The 10-year probability of survival was 87%. Development of decompensation and age were predictive of mortality.
HSS is characterized by multiple episodes of GI bleeding, a high probability of decompensation and reduced survival at the end of the first decade. Decompensation is more common in patients with varicose esophageal bleeding and is associated with lower survival.
肝脾型血吸虫病(HSS)是一种特殊形式的非肝硬化门静脉高压症(NCPH)。尽管HSS患者肝功能正常,但部分患者会出现肝细胞衰竭的体征及失代偿期肝硬化的特征。HSS-NCPH的自然病程尚不清楚。
开展一项回顾性研究,评估符合HSS临床实验室标准的患者。
共纳入105例患者。11例患者已出现失代偿性疾病,其5年无移植生存率低于未出现失代偿的患者(61%对95%,P = 0.015)。在94例无先前失代偿的患者中,中位随访时间为62个月,其中44%发生静脉曲张出血(27%有两次或更多次发作)。21例患者至少出现一次失代偿发作(10年概率为38%)。多因素分析显示,静脉曲张出血和较高胆红素水平与失代偿相关。10年生存率为87%。失代偿的发生和年龄可预测死亡率。
HSS的特点是多次胃肠道出血发作、失代偿概率高且在第一个十年末生存率降低。失代偿在食管静脉曲张出血患者中更常见,且与较低生存率相关。